KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
USD 24.50
0.00%
(0.00) 1H
1 Okt, 10:21:43 PG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk KSPHF...
Permodalan Pasaran
177.56B
Purata volum
20.00
Volum
0.00
tgi 52 mgu
USD 31.90
rdh 52 mgu
USD 24.50
Beta
13.94
Syer tertunggak
46.54J
Bilangan pekerja
2K
Permodalan Pasaran
177.56B
Purata volum
20.00
Volum
0.00
tgi 52 mgu
USD 31.90
rdh 52 mgu
USD 24.50
Beta
13.94
Syer tertunggak
46.54J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
1 hari lalu
Nasdaq climbs as chip and AI-linked stocks bounce back
Stock Titan
·
7 minit lalu
Farm and forest waste could become jet fuel. XCF Global is adding the technology.
FinancialContent
·
14 minit lalu
Medpace (NASDAQ:MEDP) reports Q3 2026 in line with expectations
The Motley Fool
·
10 minit lalu
Prediction: 2026 Will Be the S&P 500's 4th Straight Double-Digit Year
Profil
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
Perihal Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Pekerja1.79K
Diasaskan9 Ogo 1946
Ibu pejabatMatsumoto, Wilayah Nagano, Jepun
Sektor-
Laman webkissei.co.jp